Wells Fargo analyst Stephen Baxter maintained a Buy rating on CVS Health (CVS – Research Report) on March 14 and set a price target of $73.00.
In a report released on March 14, Stephen Baxter from Wells Fargo maintained a Buy rating on Humana (HUM – Research Report), with a price ...
West Yorkshire-based financial adviser, Robertson Baxter, has been acquired by financial planning business Benchmark Capital, ...